Good MorningThe rally on Wall Street hit another roadblock on Thursday despite better-than-expected economic data. The data included ISM services and factory orders which both came in better than expected. The news sent the S&P 500 up in early trading but resistance capped the gains at the key 4,150 level. If the market can not get above this level soon another round of selling could follow and there is a catalyst due out on Friday.
The NFP report is expected to show a slowdown in hiring that is also foreshadowed by the jobless claims data. The number of initial and total claims for unemployment continues to rise and suggests a topping in the labor markets. Topping in the labor market is good news for inflation but bad news for the economy because it will undercut consumer spending growth and weigh on the outlook for economic activity and corporate earnings. Featured: The A.I. Gold Rush Starts Now (Ad) 
|
Politics | | | Stocks on Wall Street closed broadly higher Wednesday as investors welcomed encouraging economic data and quarterly earnings reports from big companies including Starbucks.
The S&P 500 rose 1.6% to an almost 2-month high, while the Nasdaq gained 2.6%. Both indexes more than recoup... Read the Full Story |
|
From Our Partners | | Cold War Discovery Could Unlock $100 Trillion in Wealth
Jeff recently traveled to an American ghost town to investigate this crazy Cold War story…
Because it could hold the key to the entire $100 trillion AI boom.
It involves an American ghost town with just 30 people…
And a new twist to the AI boom that could make a lot of people rich. | | Click here to see the details on what could be the biggest tech story of this decade. |
|
Stocks | | |
Although not back to pre-pandemic levels, occupancy rates at many hotel chains are recovering. That’s the conclusion of Smith Travel Accommodations Research (STR). In the same survey, the research firm concluded that RevPAR (revenue per available room) and ADR (average daily rate) are also o... Read the Full Story |
|
Politics | | | Stocks were mixed in afternoon trading on Wall Street Thursday as investors continued to review the latest updates on the economy and corporate earnings.
The S&P 500 fell 0.1% as of 2:23 p.m. Eastern. The Dow Jones Industrial Average fell 91 points, or 0.3%, to 32,717 and the Nasd... Read the Full Story |
|
From Our Partners | | Washington is running out of money…And guess where they'll look next?
When governments go broke, they take from the people.
It's happened before, and it's happening again.
The Department of Justice just admitted that cash isn't legally YOUR property. | | Get your free guide now by clicking here >> |
|
Markets | | |
Membership warehouse club operator BJ’s Wholesale Club Holdings (NYSE: BJ) stock is one of the rare stocks actually trading up 3% for 2022. Rising inflation and fuels prices have driven the consumers to warehouse clubs away from traditional retailers as households tighten their budgets. BJ&r... Read the Full Story |
|
Markets | | |
It hasn’t been an incredibly fun year for investors in Cedar Fair (NYSE: FUN) stock. The company’s share price is down 19.5% for the year. And that loss is even worse for investors who entered a position when the stock was at its 52-week high in mid-February.
But after the amus... Read the Full Story |
|
From Our Partners | | 2025 is off to a turbulent start—markets are swinging wildly, inflation pressures remain high, and recession fears are creeping back into headlines.
But even in uncertain times, innovation doesn’t slow down.
In fact, artificial intelligence (AI) is accelerating faster than ever—creating new profit opportunities while the broader market struggles.
Our latest research reveals two AI stocks trading under $15 that could thrive even as volatility grows. These under-the-radar companies are positioned to ride the next wave of AI-driven demand—and they’re still flying below most investors’ radar. | | 👉[Click here to access your FREE AI stocks report now.] |
|
Markets | | |
FuelCell Energy (NASDAQ: FCEL) along with other stocks in the industrial sector was sold off recently following the news that the US senate would not sponsor a package that would introduce new spending to tackle climate change. Since then, the stock is currently up 2.34%, so some investors have wo... Read the Full Story |
|
Markets | | | The death toll from exploding air bag inflators made by Takata Corp. has risen to 19 in the U.S. and 28 worldwide.
Authorities say the driver of a 2006 Ford Ranger pickup truck was killed in what should have been a minor crash last month near Pensacola, Florida. But the driver's air b... Read the Full Story |
|
Tech | | | Toyota’s profit fell nearly 18% in the April-June quarter from the year before, as a semiconductor shortage that has slammed the auto industry dented production at Japan’s top automaker.
Toyota Motor Corp. reported Thursday a quarterly profit of 736.8 billion yen ($5.5 billion), down... Read the Full Story |
|
Politics | | | President Joe Biden traveled to Saudi Arabia last month on the possibility that he could get some additional oil production out of OPEC+ in coming weeks, but the cartel and other nations announced a scant increase Wednesday.
The White House responded by stressing that what matters is ... Read the Full Story |
|
Stocks | | |
MarketBeat reported that Freeport McMoran Inc (NYSE: FCX) submitted its earnings card this week. The results were mixed, with the company's net income contracting $840M from $1083M last year. The company's EPS also shrank from 0.57 to 73 cents from the same quarter last year. On a positive note, c... Read the Full Story |
|
Friday's Early Bird Stock Of The Day Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain and LX2761, which is in Phase I clinical development for gastrointestinal tract. Lexicon Pharmaceuticals, Inc. has strategic collaboration and license agreements with Bristol-Myers Squibb Company and Genentech, Inc. The company was incorporated in 1995 and is headquartered in The Woodlands, Texas. | | View Today's Stock Pick |
|
